1. Berheimer, H., Birkmaher, W., Hornykiewicz, O., Jellinger, K. and Seitelberger, F., 1973. Brain dopamine and the syndromes of Parkinson and Huntington J. Neurosci., 20, 415.
2. Bunney, B. S., 1983. Neuroleptics: Electrophysiological pharmacology. In “Neuroleptics, Neurochemical, Behavioural and Clinical Perspectives” eds, Coyle, J & Enna, S. J. Raven Press, New York.
3. Edvinsson, L., 1985. Functional role of perivascular peptides in the control of cerebral circulation. Trends in Neurol. Sci. 8, 126.
4. Fisher, D.B. and Kaufman, S., 1972. The inhibition of phenylalanine and tyrosine hydroxylases by high oxygen levels. J. Neurochem. 19, 1359.
5. Gale, K., Costa, E., Toffano, G., Hong, J.S. and Guidotti, A., 1978. Evidence for a role of nigral GABA and substance P. in the haloperido induced activation of striatal tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 206, 29.